Stefan Knapp - University of Oxford Structural Genomics Consortium (SGC), Botnar Research Centre Oxford OX3 7LD UK

基本信息

浏览量：210

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 687 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on SNAr Electrophiles

Moritz Schwarz, Maksym Kurkunov,Florian Wittlinger,Ramona Rudalska, Guiqun Wang,Martin Peter Schwalm, Alexander Rasch, Benedikt Wagner,Stefan A Laufer,Stefan Knapp,Daniel Dauch,Matthias Gehringer

Journal of medicinal chemistry (2024)

引用0浏览0WOS引用

Photosensitization enables Pauson-Khand-type reactions with nitrenes

Fang Li,W Felix Zhu,Claire Empel,Oleksandr Datsenko,Adarsh Kumar, Yameng Xu,Johanna H M Ehrler,Iuliana Atodiresei,Stefan Knapp,Pavel K Mykhailiuk,Ewgenij Proschak,Rene M Koenigs

Scienceno. 6682 (2024): 498-503

引用0浏览0WOSSCIENCE引用

tracerDB: A crowdsourced fluorescent tracer database for target engagement analysis

Martin Schwalm, Johannes Dopfer,James Vasta,Susanne Muller,Stefan Knapp,Matthew Robers

crossref（2024）

引用0浏览0引用

Development of Selective Pyrido[2,3-d]pyrimidin-7(8H)-one-Based Mammalian STE20-Like (MST3/4) Kinase Inhibitors

Marcel Rak, Amelie Menge,Roberta Tesch,Lena M. Berger,Dimitrios-Ilias Balourdas,Ekaterina Shevchenko,Andreas Kramer,Lewis Elson,Benedict-Tilman Berger,Ismahan Abdi, Laurenz M. Wahl,Antti Poso,

JOURNAL OF MEDICINAL CHEMISTRYno. 5 (2024): 3813-3842

引用0浏览0引用

Synthesis and biological evaluation of 1H-pyrrolo[3,2-g]isoquinolines

Mathilde Defois,Beatrice Josselin, Pierre Brindeau, Andreas Kraemer,Stefan Knapp,Fabrice Anizon,Francis Giraud,Sandrine Ruchaud,Pascale Moreau

BIOORGANIC & MEDICINAL CHEMISTRY (2024)

引用0浏览0引用

Development of Potent Dual BET/HDAC Inhibitors via Pharmacophore Merging and Structure-Guided Optimization

Nicolas Bauer,Dimitrios-Ilias Balourdas, Joel R. Schneider, Xin Zhang,Lena M. Berger,Benedict-Tilman Berger,Martin P. Schwalm, Nick A. Klopp, Jens T. Siveke,Stefan Knapp,Andreas C. Joerger

ACS CHEMICAL BIOLOGYno. 2 (2024): 266-279

引用0浏览0引用

Tetrahydropyridine LIMK inhibitors: Structure activity studies and biological characterization

Anthony Champiré, Rayan Berabez,Abdennour Braka, Aurélie Cosson,Justine Corret, Caroline Girardin, Amandine Serrano,Samia Aci-Sèche,Pascal Bonnet,Béatrice Josselin, Pierre Brindeau,Sandrine Ruchaud,

European Journal of Medicinal Chemistry（2024）

引用0浏览0引用

Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical Properties

Max Lewandowski, Melania Carmina, Loris Knümann, Minh Sai,Sabine Willems, Till Kasch,Julius Pollinger,Stefan Knapp,Julian A Marschner,Apirat Chaikuad,Daniel Merk

Journal of medicinal chemistryno. 3 (2024): 2152-2164

引用0浏览0WOS引用

Discovery of the sEH Inhibitor Epoxykynin as a Potent Kynurenine Pathway Modulator

Lara Dötsch,Caitlin Davies,Elisabeth Hennes, Julia Schönfeld,Adarsh Kumar, Celine Da Cruz Lopes Guita, Johanna H M Ehrler,Kerstin Hiesinger, Sasikala Thavam,Petra Janning, Sonja Sievers,Stefan Knapp,

Journal of medicinal chemistryno. 6 (2024): 4691-4706

引用0浏览0WOS引用

Development of Selective Pyrido[2,3-d]pyrimidin-7(8H)-one-Based Mammalian STE20-Like (MST3/4) Kinase Inhibitors

Marcel Rak, Amelie Menge,Roberta Tesch,Lena M Berger,Dimitrios-Ilias Balourdas, Ekaterina Shevchenko,Andreas Krämer,Lewis Elson,Benedict-Tilman Berger,Ismahan Abdi, Laurenz M Wahl,Antti Poso,

Journal of medicinal chemistryno. 5 (2024): 3813-3842

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn